Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion
J Gurevitch,
I Frolkis,
Y Yuhas,
Y Paz,
M Matsa,
R Mohr,
and
V Yakirevich
Department of Thoracic and Cardiovascular Surgery, Ichilov Hospital, Tel-Aviv, Israel.
OBJECTIVES: The purpose of this study was to examine whether tumor necrosis factor-alpha (TNF-alpha) is released directly from the ischemic myocardium undergoing reperfusion. BACKGROUND: Tumor necrosis factor-alpha is a protein hormone produced by systemic leukocytes (primarily by activated macrophages). It has been implicated as a systemic mediator in the development of septic shock and other pathologic conditions. Serum TNF-alpha has also been detected in a variety of cardiac disease states and after myocardial ischemia-reperfusion injury. METHODS: Nine isolated rat hearts undergoing 30 min of perfusion, followed by warm cardioplegic arrest, 1 h of global ischemia and 30 min of reperfusion, were investigated using the modified Langendorff model. RESULTS: Significant amounts of TNF-alpha (752 +/- 212 pmol/ml) were detected in the effluent during the first minute of reperfusion. Tumor necrosis factor-alpha levels correlated with postischemic deterioration in peak systolic pressures (r = 0.7882, p = 0.012), dP/dt max (r = 0.6795, p = 0.044), time-pressure integral (r = 0.7661, p = 0.0016) and postischemic creatine kinase levels (r = 0.8367, p = 0.005). The deterioration in coronary flow, however, was inversely correlated with TNF-alpha levels (r = -0.7581, p = 0.018). CONCLUSIONS: To our knowledge, this study is the first to suggest that the isolated rat myocardium synthesizes and releases TNF-alpha in response to ischemia and reperfusion, which directly correlates with the postischemic deterioration in myocardial mechanical performance and the amount of cellular necrosis.
This article has been cited by other articles:

|
 |

|
 |
 
Y. Shi, M. Fukuoka, G. Li, Y. Liu, M. Chen, M. Konviser, X. Chen, M. A. Opavsky, and P. P. Liu
Regulatory T Cells Protect Mice Against Coxsackievirus-Induced Myocarditis Through the Transforming Growth Factor {beta}-Coxsackie-Adenovirus Receptor Pathway
Circulation,
June 22, 2010;
121(24):
2624 - 2634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sun, M. Chen, F. Dawood, U. Zurawska, J. Y. Li, T. Parker, Z. Kassiri, L. A. Kirshenbaum, M. Arnold, R. Khokha, et al.
Tumor Necrosis Factor-{alpha} Mediates Cardiac Remodeling and Ventricular Dysfunction After Pressure Overload State
Circulation,
March 20, 2007;
115(11):
1398 - 1407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sakata, J.-W. Dong, J. G. Vallejo, C.-H. Huang, J. S. Baker, K. J. Tracey, O. Tacheuchi, S. Akira, and D. L. Mann
Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol,
January 1, 2007;
292(1):
H503 - H509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lecour, N. Suleman, G. A. Deuchar, S. Somers, L. Lacerda, B. Huisamen, and L. H. Opie
Pharmacological Preconditioning With Tumor Necrosis Factor-{alpha} Activates Signal Transducer and Activator of Transcription-3 at Reperfusion Without Involving Classic Prosurvival Kinases (Akt and Extracellular Signal-Regulated Kinase)
Circulation,
December 20, 2005;
112(25):
3911 - 3918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Chao, Y. Shen, L. Li, H. Zhao, S. E. Meiler, S. A. Cook, and A. Rosenzweig
Fas-associated death-domain protein inhibits TNF-{alpha} mediated NF-{kappa}B activation in cardiomyocytes
Am J Physiol Heart Circ Physiol,
November 1, 2005;
289(5):
H2073 - H2080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zhang, Y.-J. Xu, H. K. Saini, B. Turan, P. P. Liu, and N. S. Dhalla
Pentoxifylline attenuates cardiac dysfunction and reduces TNF-{alpha} level in ischemic-reperfused heart
Am J Physiol Heart Circ Physiol,
August 1, 2005;
289(2):
H832 - H839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sharony, I. Frolkis, D. Froylich, S. M. Wildhirt, I. Shapira, B. Reichart, N. Nesher, and G. Uretzky
Pharmacological preconditioning with monophosphoryl lipid A improves post ischemicdiastolic function and modifies TNF-alpha synthesis
Eur J Cardiothorac Surg,
March 1, 2005;
27(3):
501 - 507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lecour, L. Rochette, and L. Opie
Free radicals trigger TNF{alpha}-induced cardioprotection
Cardiovasc Res,
January 1, 2005;
65(1):
239 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. M. Fischer, P. Tossios, A. Huebner, H. J. Geissler, W. Bloch, and U. Mehlhorn
Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery
J. Thorac. Cardiovasc. Surg.,
July 1, 2004;
128(1):
103 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Schulz, M. Kelm, and G. Heusch
Nitric oxide in myocardial ischemia/reperfusion injury
Cardiovasc Res,
February 15, 2004;
61(3):
402 - 413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Rossoni, B. Manfredi, V. Cavalca, R. Razzetti, S. Bongrani, G. L. Polvani, and F. Berti
The Aminotetraline Derivative ({+/-})-(R,S)-5,6-Dihydroxy-2-methylamino-1,2,3,4-tetrahydro-naphthalene Hydrochloride (CHF-1024) Displays Cardioprotection in Postischemic Ventricular Dysfunction of the Rat Heart
J. Pharmacol. Exp. Ther.,
November 1, 2003;
307(2):
633 - 639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Paz, I. Frolkis, D. Pevni, I. Shapira, Y. Yuhas, A. Iaina, Y. Wollman, T. Chernichovski, N. Nesher, C. Locker, et al.
Effect of tumor necrosis Factor-Alphaon endothelial and inducible nitric oxidesynthase messenger ribonucleic acidexpression and nitric oxide synthesisin ischemic and nonischemic isolated rat heart
J. Am. Coll. Cardiol.,
October 1, 2003;
42(7):
1299 - 1305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Kown, M. A. Lijkwan, C. L. Jahncke, S. Murata, J. B. Rothbard, and R. C. Robbins
L-arginine polymers enhance coronary flow and reduce oxidative stress following cardiac transplantation in rats
J. Thorac. Cardiovasc. Surg.,
October 1, 2003;
126(4):
1065 - 1070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. I. Dibbs, A. Diwan, S. Nemoto, G. DeFreitas, M. Abdellatif, B. A. Carabello, F. G. Spinale, G. Feuerstein, N. Sivasubramanian, and D. L. Mann
Targeted Overexpression of Transmembrane Tumor Necrosis Factor Provokes a Concentric Cardiac Hypertrophic Phenotype
Circulation,
August 26, 2003;
108(8):
1002 - 1008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Aker, S. Belosjorow, I. Konietzka, A. Duschin, C. Martin, G. Heusch, and R. Schulz
Serum but not myocardial TNF-{alpha} concentration is increased in pacing-induced heart failure in rabbits
Am J Physiol Regulatory Integrative Comp Physiol,
August 1, 2003;
285(2):
R463 - R469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Qing, K. Schumacher, R. Heise, M. Woltje, J. F. Vazquez-Jimenez, T. Richter, M. Arranda-Carrero, J. Hess, G.o. von Bernuth, and M.-C. Seghaye
Intramyocardial synthesis of pro- and anti-inflammatory cytokines in infants with congenital cardiac defects
J. Am. Coll. Cardiol.,
June 18, 2003;
41(12):
2266 - 2274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. M. Fischer, O. Klass, U. Stock, J. Easo, H. J. Geissler, J. H. Fischer, W. Bloch, and U. Mehlhorn
Cardioplegic arrest induces apoptosis signal-pathway in myocardial endothelial cells and cardiac myocytes
Eur J Cardiothorac Surg,
June 1, 2003;
23(6):
984 - 990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Calabresi, G. Rossoni, M. Gomaraschi, F. Sisto, F. Berti, and G. Franceschini
High-Density Lipoproteins Protect Isolated Rat Hearts From Ischemia-Reperfusion Injury by Reducing Cardiac Tumor Necrosis Factor-{alpha} Content and Enhancing Prostaglandin Release
Circ. Res.,
February 21, 2003;
92(3):
330 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. X. Zhang, F.-X. Yi, A.-P. Zou, and P.-L. Li
Role of ceramide in TNF-alpha -induced impairment of endothelium-dependent vasorelaxation in coronary arteries
Am J Physiol Heart Circ Physiol,
November 1, 2002;
283(5):
H1785 - H1794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M Smith, N. Suleman, J. McCarthy, and M. N Sack
Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNF{alpha} gene
Cardiovasc Res,
August 15, 2002;
55(3):
553 - 560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Stangl, G. Baumann, K. Stangl, and S. B Felix
Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion
Cardiovasc Res,
January 1, 2002;
53(1):
12 - 30.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R Holleyman and D. F Larson
Apoptosis in the ischemic reperfused myocardium
Perfusion,
December 1, 2001;
16(6):
491 - 502.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C A Dinarello
Novel targets for interleukin 18 binding protein
Ann Rheum Dis,
November 1, 2001;
60(90003):
iii18 - 24.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Grunenfelder, D. N. Miniati, S. Murata, V. Falk, E. G. Hoyt, M. Kown, M. L. Koransky, and R. C. Robbins
Upregulation of Bcl-2 Through Caspase-3 Inhibition Ameliorates Ischemia/Reperfusion Injury in Rat Cardiac Allografts
Circulation,
September 18, 2001;
104(2009):
I-202 - I-206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Stamm, I. Friehs, D. B. Cowan, A. M. Moran, H. Cao-Danh, L. F. Duebener, P. J. del Nido, and F. X. McGowan Jr
Inhibition of Tumor Necrosis Factor-{alpha} Improves Postischemic Recovery of Hypertrophied Hearts
Circulation,
September 18, 2001;
104(2009):
I-350 - I-355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Li, R. L. Kao, T. Ha, J. Kelley, I. W. Browder, and D. L. Williams
Early activation of IKK{beta} during in vivo myocardial ischemia
Am J Physiol Heart Circ Physiol,
March 1, 2001;
280(3):
H1264 - H1271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Pomerantz, L. L. Reznikov, A. H. Harken, and C. A. Dinarello
Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1{beta}
PNAS,
February 27, 2001;
98(5):
2871 - 2876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Frolkis, J. Gurevitch, Y. Yuhas, A. Iaina, Y. Wollman, T. Chernichovski, Y. Paz, M. Matsa, D. Pevni, A. Kramer, et al.
Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemia
J. Am. Coll. Cardiol.,
January 1, 2001;
37(1):
316 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D B. Sanders, D. F Larson, K. Hunter, M. Gorman, and B. Yang
Comparison of tumor necrosis factor-effect on the expression of iNOS in macrophage and cardiac myocytes
Perfusion,
January 1, 2001;
16(1):
67 - 74.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Wilhelm, J. Pratschke, F. Beato, M. Taal, M. Kusaka, W. W. Hancock, and N. L. Tilney
Activation of the Heart by Donor Brain Death Accelerates Acute Rejection After Transplantation
Circulation,
November 7, 2000;
102(19):
2426 - 2433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Bull, R. C. Connors, A. Albanil, B. B. Reid, L. A. Neumayer, R. Nelson, J. C. Stringham, and S. V. Karwande
APROTININ PRESERVES MYOCARDIAL BIOCHEMICAL FUNCTION DURING COLD STORAGE THROUGH SUPPRESSION OF TUMOR NECROSIS FACTOR
J. Thorac. Cardiovasc. Surg.,
February 1, 2000;
119(2):
242 - 250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Sack, R. M. Smith, and L. H. Opie
Tumor necrosis factor in myocardial hypertrophy and ischaemia -- an anti-apoptotic perspective
Cardiovasc Res,
February 1, 2000;
45(3):
688 - 695.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Belosjorow, R. Schulz, H. Dorge, F. U. Schade, and G. Heusch
Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits
Am J Physiol Heart Circ Physiol,
December 1, 1999;
277(6):
H2470 - H2475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Simms and K. R. Walley
Activated macrophages decrease rat cardiac myocyte contractility: importance of ICAM-1-dependent adhesion
Am J Physiol Heart Circ Physiol,
July 1, 1999;
277(1):
H253 - H260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Li, B. Yang, and J. L. Mehta
Tumor necrosis factor-{alpha} enhances hypoxia-reoxygenation-mediated apoptosis in cultured human coronary artery endothelial cells: critical role of protein kinase C
Cardiovasc Res,
June 1, 1999;
42(3):
805 - 813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, M. Pasparakis, G. Kollias, and M. Simons
Myocyte-dependent Regulation of Endothelial Cell Syndecan-4 Expression. ROLE OF TNF-alpha
J. Biol. Chem.,
May 21, 1999;
274(21):
14786 - 14790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Kupatt, H. Habazettl, A. Goedecke, D. A. Wolf, S. Zahler, P. Boekstegers, R. A. Kelly, and B. F. Becker
Tumor Necrosis Factor-{alpha} Contributes to Ischemia- and Reperfusion-Induced Endothelial Activation in Isolated Hearts
Circ. Res.,
March 5, 1999;
84(4):
392 - 400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Li, B. Yang, M. I. Philips, and J. L. Mehta
Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of AT1 receptor and PKC activation
Am J Physiol Heart Circ Physiol,
March 1, 1999;
276(3):
H786 - H792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Alloatti, C. Penna, A. De Martino, G. Montrucchio, and G. Camussi
Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-{alpha} in the guinea-pig papillary muscle
Cardiovasc Res,
March 1, 1999;
41(3):
611 - 619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Liu, W. Zhou, and R. H. Kennedy
Suppression of beta -adrenergic responsiveness of L-type Ca2+ current by IL-1beta in rat ventricular myocytes
Am J Physiol Heart Circ Physiol,
January 1, 1999;
276(1):
H141 - H148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Li, B. Yang, and J. L. Mehta
Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas
Am J Physiol Heart Circ Physiol,
August 1, 1998;
275(2):
H568 - H576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-S. Lee, M. K. Jain, B. M. Arkonac, D. Zhang, S.-Y. Shaw, S. Kashiki, K. Maemura, S.-L. Lee, N. K. Hollenberg, M.-E. Lee, et al.
Thy-1, a Novel Marker for Angiogenesis Upregulated by Inflammatory Cytokines
Circ. Res.,
May 4, 1998;
82(8):
845 - 851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Meldrum
Tumor necrosis factor in the heart
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 1998;
274(3):
R577 - R595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Meldrum, J. C. Cleveland Jr, B. S. Cain, X. Meng, and A. H. Harken
Increased Myocardial Tumor Necrosis Factor-{alpha} in a Crystalloid-Perfused Model of Cardiac Ischemia-Reperfusion Injury
Ann. Thorac. Surg.,
February 1, 1998;
65(2):
439 - 443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. I. Gudz, K.-Y. Tserng, and C. L. Hoppel
Direct Inhibition of Mitochondrial Respiratory Chain Complex III by Cell-permeable Ceramide
J. Biol. Chem.,
September 26, 1997;
272(39):
24154 - 24158.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|